Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

2.

Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells.

Katz HR.

Mol Immunol. 2002 Sep;38(16-18):1301-5. Review.

PMID:
12217399
3.

Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction.

Tamir I, Dal Porto JM, Cambier JC.

Curr Opin Immunol. 2000 Jun;12(3):307-15. Review.

PMID:
10781410
4.

Mast cell regulation via paired immunoglobulin-like receptor PIR-B.

Chen CC, Kong DW, Cooper MD, Kubagawa H.

Immunol Res. 2002;26(1-3):191-7. Review.

PMID:
12403357
5.

SHP-2, SH2-containing protein tyrosine phosphatase-2.

Stein-Gerlach M, Wallasch C, Ullrich A.

Int J Biochem Cell Biol. 1998 May;30(5):559-66. Review.

PMID:
9693956
6.

Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases.

Siminovitch KA, Neel BG.

Semin Immunol. 1998 Aug;10(4):329-47. Review.

PMID:
9695189
7.

Protein tyrosine phosphatases: mechanisms of catalysis and regulation.

Denu JM, Dixon JE.

Curr Opin Chem Biol. 1998 Oct;2(5):633-41. Review.

PMID:
9818190
8.
9.

Surface makers for mast cell subtypes: low affinity IgG receptors and gp49 family.

Castells MC.

Allerg Immunol (Paris). 1994 Apr;26(4):127-31. Review.

PMID:
8031457
10.

Inhibitory receptors, ITIM sequences and phosphatases.

Unkeless JC, Jin J.

Curr Opin Immunol. 1997 Jun;9(3):338-43. Review.

PMID:
9203414
11.

[Mast cell inhibitory receptors].

Bąbolewska E, Brzezińska-Błaszczyk E.

Postepy Hig Med Dosw (Online). 2012 Oct 22;66:739-51. doi: 10.5604/17322693.1015039. Review. Polish.

12.

Inhibitory receptors abound?

Cambier JC.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):5993-5. Review. No abstract available.

13.

Turning off natural killers. Innate immunity.

Imboden J.

Curr Biol. 1996 Sep 1;6(9):1070-2. Review.

14.

Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency.

Shultz LD, Rajan TV, Greiner DL.

Trends Biotechnol. 1997 Aug;15(8):302-7. Review.

PMID:
9263478
15.

What precedes the initial tyrosine phosphorylation of the high affinity IgE receptor in antigen-activated mast cell?

Bugajev V, Bambousková M, Dráberová L, Dráber P.

FEBS Lett. 2010 Dec 15;584(24):4949-55. doi: 10.1016/j.febslet.2010.08.045. Epub 2010 Sep 7. Review.

16.

The tyrosine kinase network regulating mast cell activation.

Gilfillan AM, Rivera J.

Immunol Rev. 2009 Mar;228(1):149-69. doi: 10.1111/j.1600-065X.2008.00742.x. Review.

17.

The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?

Scharenberg AM, Kinet JP.

Cell. 1996 Dec 13;87(6):961-4. Review. No abstract available.

18.

Inhibitory leukocyte immunoglobulin-like receptors in cancer development.

Zhang F, Zheng J, Kang X, Deng M, Lu Z, Kim J, Zhang C.

Sci China Life Sci. 2015 Dec;58(12):1216-25. doi: 10.1007/s11427-015-4925-1. Epub 2015 Nov 14. Review.

PMID:
26566804
19.

Expression and function of an IgE-binding animal lectin (epsilon BP) in mast cells.

Liu FT, Frigeri LG, Gritzmacher CA, Hsu DK, Robertson MW, Zuberi RI.

Immunopharmacology. 1993 Nov-Dec;26(3):187-95. Review.

PMID:
8288440
20.

Negative regulation of mast cell proliferation by FcgammaRIIB.

Malbec O, Attal JP, Fridman WH, Daëron M.

Mol Immunol. 2002 Sep;38(16-18):1295-9. Review.

PMID:
12217398

Supplemental Content

Support Center